Read the consumer reviews for AG1, and something strange becomes obvious.
Nobody talks about the ingredients. Nobody quotes the clinical trials. Nobody compares dosages or bioavailability. Instead, they say things like this:
"AG1 has become the foundation of my daily nutrition."
"It gives me peace of mind that I'm doing something good for my future health."
"AG1 became part of my routine like brushing my teeth."
"My mornings feel locked in thanks to AG1."
Foundation. Peace of mind. Locked in. Like brushing my teeth. These are not people describing a supplement. They are describing a ritual. A daily, 30-second act of moral self-regulation that converts health anxiety into a feeling of agency.
That distinction is the entire brand.
What most people get wrong
The surface story is that AG1 makes a science-backed premium greens powder, marketed through podcasts, priced at a premium because the formulation justifies it.
Every part of that story is partially true and entirely incomplete.
The science is real but limited. McGill University's Office for Science and Society describes the blend as "backed by very little scientific support." Harvard's JoAnn Manson has said AG1's trials lack the rigour of large-scale randomised controlled trials. 75 ingredients in a single scoop means most individual nutrients are present at levels too low to produce meaningful clinical effects on their own.
A Costco multivitamin covers your nutritional bases for a fraction of the cost. AG1 charges roughly $79 per month for its subscription, more than double most competitors’.
And yet revenue has grown from $150 million in 2021 to a projected $600 million in 2024. The brand has spent over $27 million on podcast advertising alone since 2022, more than any other supplement brand. Criticism from scientists, dietitians, and investigative journalists has not slowed it.
If the product were the point, none of this would add up. The product is not the point.
The brand strategy underneath
AG1 does not compete in the supplement category. It competes in the identity category.
The core customer is not the biohacker stereotype. CEO Kat Cole has stated the audience is 50/50 male and female, with the fastest-growing cohorts being women over 40, busy professionals, and the over-55 longevity audience. The 2021 rebrand from Athletic Greens to AG1 happened because the word "athletic" was alienating half the customer base.
The psychographic core is what you might call the responsible optimiser. Someone who believes individual responsibility is the lever for health. Someone who feels underserved or actively distrustful of institutional medicine. Someone who is time-poor, decision-fatigued, and wants a single daily action that converts their worldview into practice.
The ritual is the brand. One scoop. One glass. Every morning. Thirty seconds that say: I am the kind of person who takes their health seriously. I am not leaving this to chance.
Cultural sociologist Robert Crawford identified this pattern decades ago under the term "healthism," which is health framed as a personal moral responsibility achieved through disciplined lifestyle modification. AG1 is the commodity expression of that ideology. It is a 30-second proof of virtue. And in a cultural moment where biological capital (sleep scores, HRV, cold plunges, sauna minutes) has displaced material consumption as the dominant status signal among affluent consumers, that proof of virtue carries real social weight.
The AG1 buyer would be embarrassed to be seen with a Centrum bottle. Not because Centrum is inferior. Because Centrum signals passive compliance with mainstream medicine. AG1 signals active health ownership. The price is not a barrier. It is the membership fee.
What makes the brand strategy work
Three strategic decisions built AG1's meaning system. Each one prioritises identity over efficacy.
1. They built trust through parasocial relationships, not advertising.
AG1's dominant marketing channel is host-read podcast endorsements. Andrew Huberman. Tim Ferriss. Joe Rogan. Peter Attia. Lex Fridman. These are not celebrity endorsers reading a script. They are voices that millions of people listen to alone, in their ears, for hours every week.
Peer-reviewed research shows that parasocial relationships with podcast hosts decrease what psychologists call evaluative persuasion knowledge. Listeners literally process a host-read AG1 spot as a friend's recommendation rather than an ad. A major study found 75% of podcast listeners value a podcaster's influence more than social media influencers (15%) or TV celebrities (10%). 52% are more likely to try a product recommended by the host of their favourite podcast.
AG1 does not buy advertising. It buys identity transfer. When Huberman takes AG1 on camera every morning, the implicit message is not "this product is good." The message is: the kind of person you aspire to be takes this every morning. If you take it too, you are one step closer to being that person.
For CPG founders: the channel is not the innovation here. The mechanism is. AG1 understood that trust is not built through reach. It is built through intimacy. Find the voices your customer already trusts, the ones they listen to alone, and earn a genuine endorsement. That endorsement will outperform any advertising campaign because it bypasses the part of the brain that evaluates ads.
2. They designed a ritual, not a product.
AG1's competitive moat is not the powder. It is the daily practice.
One scoop. One glass. Every morning. The same time. The same motion. The ritual is binary (you did it or you did not), time-locked (morning), and visible (the green glass on the counter signals to yourself and anyone watching that you are someone who does this).
This positions AG1 alongside Headspace, the Five Minute Journal, and the Oura ring, products that sell daily reaffirmation of an identity, not alongside Centrum or Bloom.
The ritual creates psychological lock-in that no ingredient list can match. Switching to a cheaper greens powder means breaking a morning practice that has become part of how you see yourself. You are not switching supplements. You are abandoning a version of yourself.
For CPG founders: if your product is consumed once and evaluated on its merits, you are competing on features. If your product is embedded in a daily ritual that becomes part of how your customer defines themselves, you are competing on identity. The second is exponentially harder to displace.
3. They used premium pricing as a tribal gate.
At $79 a month, AG1 costs more than double most competitors. Bloom is $35. Primal Greens is roughly $40. The price does not reflect proportionally superior ingredients.
The price reflects the identity cost of admission. Cultural researcher Charlotte Biltekoff has described how green powders signal "wealth, discipline, and responsibility, all of which, taken together, reflect and express status." The premium is not a barrier to purchase. It is the barrier that makes the purchase meaningful. If AG1 cost $20, it would not signal the same identity. A Substack writer titled her review "I joined the cult of AG1," capturing the truth that the willingness to pay is the membership card.
For CPG founders who think they need to compete on price: AG1 proves the opposite. In an identity-driven category, lowering the price does not attract more customers. It destroys the signal that attracted them in the first place.
Where AG1's meaning fractures
The risks are specific and real.
The founder mythology, which served as the emotional spine of the brand, has taken significant damage. Chris Ashenden's origin story (a health crisis, $35,000 in tests, a 50-pill-a-day regimen) was the trust anchor. Investigative reporting revealed that before founding the company, Ashenden was found guilty of breaches of New Zealand's Fair Trading Act for a property scheme a judge described as containing "strong elements of cynicism and the calculated exploitation of people." He stepped down as CEO in October 2024.
The parasocial trust architecture is powerful but concentrated. If Huberman, Attia, or Ferriss end their partnerships, the identity-transfer chain breaks in months, not years. AG1's meaning lives in those relationships. Without them, it is a green powder in a pouch competing against dozens of alternatives on ingredient lists and price.
And the broader cultural risk: the scientific scepticism has not hurt the brand yet because criticism from "the establishment" gets reinterpreted by the tribe as confirmation that AG1 is outside the failed mainstream. But that dynamic only holds as long as the tribe feels like an identity worth performing. If wellness-as-status shifts, if the cultural moment moves on, the ritual loses its social weight and the $79 price tag stops being a membership fee and starts being an expense.
The brand lesson for founders
One lesson that should reframe how you think about product development.
The product is the fourth most important asset in AG1's brand.
The three that matter more, in order: a binary daily ritual, a parasocial trust infrastructure, and premium pricing as an identity gate. The product sits underneath all three. It needs to be credible enough that the science objection does not collapse the meaning system. It does not need to be the best. It needs to be the most meaningful.
If you are a CPG founder spending 90% of your energy on your formulation and 10% on what your brand means to the person buying it, you have the ratio inverted. AG1 proved that a contested product inside a powerful meaning system will outsell a superior product inside an empty one every single time.
Build the ritual. Earn the trust. Set the price. Then make the product good enough to deserve all three.